Daily Archives: January 16, 2012

Stem Cell Therapy in Australia: Developments and Updates

Published by:

Stem Cell Therapy in Australia: Developments and Updates. This is Health Care Zone’s attempt to monitor the developments of stem cell research and treatments (if any) in the Land Down Under. We’ll report on scammy practitioners and clinics (if any), academic studies whether they’re promising or blah, stem cell trials and experiments by drug companies (if any), and what Australian health authorities are saying about the exciting world of stem cells and what they’re doing about the challenges this brave new world poses.

We’ll keep you posted. And come back for updates on stem cell therapy in Australia.

Continue reading

Prostate Cancer Robotic Surgery Side Effects: Impotence & Incontinence?

Published by:

Marketing, profit drive demand for robotic surgeries: Aggressive marketing is driving exploding demand for robotic-assisted surgery for prostate cancer, even if new research shows that it isn’t any better than low-tech surgery.

And marketing, in turn, is driven by big bucks that makers and operators of the new laparoscopic robots can make, the New York Times suggests in a report.

One in six American men develop prostate cancer in their lifetime. Treatment options include radiation and watchful waiting, but the most popular is surgery.

Continue reading

NuvaRing Blood Clot Risks and Side Effects: Is It Safe for You to Use?

Published by:

NuvaRing Blood Clot Risks and Side Effects: Is It Safe for You to Use? Are you thinking about using the NuvaRing, the birth control vaginal ring? If so, take note: health experts say that women wanting to use NuvaRing because of its effectiveness and convenience must balance these qualities against the fact that the contraceptive may pose a higher risk for blood clots.

The world’s first when it was approved by health regulators in 2001 and hailed as a “no-muss/no-fuss alternative” to the birth control pill, NuvaRing is currently facing a massive, multidistrict federal case in the United States over safety issues. Trials are scheduled to begin this year.

Continue reading